The red-emitting (650 nm) HER2Ab-QDs (prepared by using SMCC coupling to reduced antibodies) are most effective and quantitative for imaging of HER2 expression in the breast cancer cells. This evidence concerns the gene ERBB2 and breast carcinoma.